Boards of Directors

Global Board of Directors

Karen Etchberger, CSL Behring - Chair
David Bell, Grifols
David Gao, Bio Products Laboratory
Julie Kim, Takeda
Paolo Marcucci, Kedrion SpA
Michael Ramroth, Biotest AG

Europe Board of Directors

Oliver Schmitt, CSL Behring GmbH - Chair
Paul Boeckmann, Bio Products Laboratory
Thierry Heinrich, Grifols Deutschland GmbH
Roberto Tana, Kedrion
Eric Thomas, Biotest
Kasha Witkos, Takeda

North America Board of Directors

Neal Fitzpatrick, Kedrion Biopharma, Inc. - Chair
Adam Grossman, ADMA Biologics, Inc.
Bob Lojewski, CSL Behring
Bob Rossilli, Bio Products Laboratory
Laura Saward, Emergent BioSolutions Inc.
Ramona Sequeira, Takeda
Bill Zabel, Grifols

Source Board of Directors

Roger Brinser, Takeda/BioLife - Chair
Peter Allen, Grifols Plasma Operations
Jay Bae, GCAM, Inc.
Bill Bees, Prometic Plasma Resources
Marvin Dyke, BPL Plasma
Milan Maly, UNICAplasma s.r.o.
Rudolf Meixner, PlasmaVita Healthcare GmbH
Paolo Melloni, Kedrion
David Morad, Southern Blood Services
Dr. Martin Reinecke, Biotest AG
Craig Shelanskey, CSL Plasma

PPTA News

PPTA Statement on FDA Guidance Documents +

PPTA is aware of the guidance documents released by the U.S. Food and Drug Administration on April 2 regarding Source plasma donor eligibility and is currently evaluating them. Our focus remains, as it has for nearly three decades, on patient and donor safety, and the safety of therapies derived from plasma.
Read More
PPTA Responds to The Guardian Article +

An article published March 25 by Stefanie Dodt and Samuel Gilbert in The Guardian continues the authors’ intentional maligning of plasma donors along the U.S.-Mexico border and perpetuates a divisive misrepresentation of the reality of border life between the United States and Mexico. The Plasma Protein Therapeutics Association (PPTA) and its member companies are grateful for every plasma donor, each of whom directly contributes to saving and improving the lives of people facing serious, inherited, and life-threatening diseases.
Read More
Letter to CMS to Allow Home Infusion COVID +

Dear Administrator Verma,

I am writing to ask for your consideration as the Centers for Medicare and Medicaid Services explores avenues to protect vulnerable patient populations during the COVID-19 pandemic. The Plasma Protein Therapeutics Association (PPTA) is the standard setting and global advocacy organization that represents plasma donation centers and manufacturers of plasma protein therapies. Our membership accounts for approximately 80% of plasma therapies in the United States. These therapies treat individuals with rare, chronic, and life-threatening conditions, such as immune deficiencies, certain neurological diseases, alpha-1 antitrypsin deficiency, and bleeding disorders.
Read More
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies +

PPTA considers that the SARS-CoV-2 outbreak is not a concern for the safety of plasma protein therapies manufactured by PPTA member companies. The assessment is shared by notable international and national public health bodies, including the WHO, the ECDC, and others.
Read More

1
2
3

› ‹

Mission Video

Learn more about the need for plasma donors, plasma donation, and how you can save and improve lives. Find a Donation Center.

"How Is Your Day?" is an initiative to raise awareness of the unique nature of plasma protein therapies and the value they provide to patients. It aims to inform and educate decision makers and the general public worldwide.

Get involved and follow "How Is Your Day?" on social media @HIYDglobal

Media and Information

Advocacy

Copyright © 2020 PPTA. All rights reserved. (202) 789-3100

Terms of Use | Privacy Statement | Sitemap